Pharmacology, Toxicology and Pharmaceutical Science
Age Related Macular Degeneration
100%
Nanocomposite
100%
Verteporfin
100%
Doxorubicin
83%
Eye Drops
75%
Nicotinic Acid
50%
Low Density Lipoprotein
50%
Breast Cancer
50%
Chemotherapy
50%
Mesoporous Silica
50%
Tissue Repair
50%
Methacrylate
33%
Neoplasm
33%
Malignant Neoplasm
33%
Eye Injury
25%
Subretinal Neovascularization
25%
6 Carboxyfluorescein
25%
Vasculotropin Inhibitor
25%
Intercellular Adhesion Molecule 1
25%
Low Density Lipoprotein Receptor
25%
Penetratin
25%
Lipoprotein A
25%
Vasculotropin
25%
Neovascularization (Pathology)
25%
Peptide
25%
Mouse
16%
Polymer
16%
Prematurity
16%
Combination Therapy
16%
Tumor Growth
16%
Irradiation
16%
Radiation
16%
Nanocarrier
16%
Gold Nanorod
16%
Hyperthermia
16%
Diseases
16%
Water
16%
Nanogel
16%
Biopolymer
16%
Antiinfective Agent
16%
Medicine and Dentistry
Cas9
100%
Age Related Macular Degeneration
100%
Verteporfin
100%
Clustered Regularly Interspaced Short Palindromic Repeat
91%
Eye Drops
75%
Obstetric Delivery
50%
Niacin
50%
Low-Density Lipoprotein
50%
Serositis
50%
Development
41%
6 Carboxyfluorescein
25%
Penetratin
25%
Local Therapy
25%
Vasculotropin
25%
Vasculotropin Inhibitor
25%
Blood-Retinal Barrier
25%
Choroidal Neovascularization
25%
Intercellular Adhesion Molecule 1
25%
LDL Receptor
25%
Eye Injury
25%
Lesion
25%
Combination Therapy
25%
Aptitude
25%
Nanoparticle
25%
Peptide
25%
Single Drug Dose
25%
Injection
25%
Diseases
25%
Gene
16%
Bone Tissue
16%
Attention
16%
Diagnosis
16%
Water
16%
Nerve Regeneration
16%
Antiinfective Agent
16%
Researcher
8%
Proteinase
8%
Gene Therapy
8%
In Vitro
8%
Target Cell
8%
Hope
8%
Face
8%
Biochemistry, Genetics and Molecular Biology
Age
100%
CRISPR/Cas9
91%
Low-Density Lipoprotein
75%
Vascular Endothelial Growth Factor
50%
Single Drug Dose
25%
Peptide
25%
Intercellular Adhesion Molecule
25%
Neovascularization (Pathology)
25%
Carboxyfluorescein
25%
Aptitude
25%
Development
25%
Blood Retina Barrier
25%
Subretinal Neovascularization
25%
Surface Property
25%
Photodynamics
25%
Genome Editing
16%
Hope
8%
Gene Therapy
8%
Protease
8%
Target Cell
8%
Target Organ
8%
Cas9
8%
